Sign In
Buy IRMD
$91.12
+1.26 (+1.40%)
At Close: Jun 03, 2026
IRADIMED CORPORATION (IRMD) Q3 2025 Earnings Call Transcript
02:26pm, Monday, 03'rd Nov 2025
IRADIMED CORPORATION ( IRMD ) Q3 2025 Earnings Call November 3, 2025 11:00 AM EST Company Participants Roger Susi - Founder, Chairman, CEO & President John Glenn - CFO & Corporate Secretary Conference
IRADIMED CORPORATION Reports Record Third Quarter 2025 Financial Results
08:30am, Monday, 03'rd Nov 2025
Announces Regular Quarterly Cash Dividend of $0.17 Per Share and Raises Full-Year Guidance Announces Regular Quarterly Cash Dividend of $0.17 Per Share and Raises Full-Year Guidance
IRADIMED CORPORATION to Hold Third Quarter of 2025 Financial Results Conference Call on November 3, 2025
04:05pm, Monday, 27'th Oct 2025
ORLANDO, Fla., Oct. 27, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2025 third quarter financial results before the market opens on M
What Makes iRadimed (IRMD) a New Buy Stock
01:01pm, Thursday, 18'th Sep 2025
iRadimed (IRMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
IRADIMED CORPORATION to Participate in the 2025 Wells Fargo Healthcare Conference
04:05pm, Tuesday, 26'th Aug 2025
ORLANDO, Fla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in innovative medical devices for Magnetic Resonance Imaging (“MRI”) compatible patient monitoring an
IRadimed: Continued Value Unlock With Extensive Reinvestment Runway
11:24am, Thursday, 21'st Aug 2025
IRadimed Corporation demonstrates exceptional economic characteristics, with high NOPAT margins, robust free cash flow, and consistent value creation for shareholders. Management has effectively reinv
Recent Price Trend in iRadimed (IRMD) is Your Friend, Here's Why
09:50am, Thursday, 07'th Aug 2025
iRadimed (IRMD) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Iradimed (IRMD) Q2 Revenue Jumps 14%
02:54am, Saturday, 02'nd Aug 2025
Iradimed (IRMD) Q2 Revenue Jumps 14%
IRADIMED CORPORATION (IRMD) Q2 2025 Earnings Call Transcript
01:04pm, Friday, 01'st Aug 2025
IRADIMED CORPORATION (NASDAQ:IRMD ) Q2 2025 Earnings Conference Call August 1, 2025 11:00 AM ET Company Participants John F. Glenn - CFO & Corporate Secretary Roger E.
iRadimed (IRMD) Q2 Earnings and Revenues Surpass Estimates
10:46am, Friday, 01'st Aug 2025
iRadimed (IRMD) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.42 per share a year ago.
IRADIMED CORPORATION Reports Record Second Quarter 2025 Financial Results
08:30am, Friday, 01'st Aug 2025
Announces Regular Quarterly Cash Dividend of $0.17 Per Share Raises Full Year 2025 Revenue and Earnings Guidance Reports record revenue of $20.4 million for the second quarter of 2025, an increase of
IRADIMED CORPORATION to Hold Second Quarter of 2025 Financial Results Conference Call on August 1, 2025
04:05pm, Friday, 25'th Jul 2025
ORLANDO, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2025 second quarter financial results before the market opens on
New Strong Sell Stocks for June 12th
07:11am, Thursday, 12'th Jun 2025
LYB, IRMD and SONY have been added to the Zacks Rank #5 (Strong Sell) List on June 12, 2025.
IRADIMED CORPORATION Announces FDA 510(k) Clearance for MRidium® 3870 Infusion Pump System
08:30am, Thursday, 29'th May 2025
WINTER SPRINGS, Fla., May 29, 2025 (GLOBE NEWSWIRE) -- Iradimed Corporation (NASDAQ: IRMD), a global leader in innovative medical devices for MRI environments, today announced that the U.S. Food and D
IRADIMED CORPORATION (IRMD) Q1 2025 Earnings Call Transcript
02:52pm, Monday, 05'th May 2025
IRADIMED CORPORATION (NASDAQ:IRMD ) Q1 2025 Earnings Conference Call May 5, 2025 9:00 AM ET Company Participants Roger Susi - Founder, President & CEO John Glenn - CFO Conference Call Participants Fra
